Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel N Silverman

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
JAMA Network Open|December 5, 2019
Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT TrialDaniel N Silverman, Timothy B Plante, Margaret Infeld, et al.
JACC. Heart Failure|May 4, 2023
Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection FractionSuzanne V Arnold, Daniel N Silverman, Kensey Gosch, et al.
Current Heart Failure Reports|March 19, 2025
Epicardial Fat in Heart Failure and Preserved Ejection Fraction: Novel Insights and Future PerspectivesJacob Whitman, Elie Kozaily, Erin D Michos, et al.
Heart Rhythm O2|March 4, 2022
Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction: Design and rationale for the <i>my</i>PACE randomized controlled trialMargaret Infeld, Kramer Wahlberg, Jillian Cicero, et al.
Heart Rhythm O2|February 19, 2021
An approach towards individualized lower rate settings for pacemakersMargaret Infeld, Robert Avram, Kramer Wahlberg, et al.
The American Journal of Cardiology|December 15, 2021
Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial)Daniel N Silverman, Jeanne du Fay de Lavallaz, Timothy B Plante, et al.
JAMA Cardiology|February 1, 2023
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical TrialMargaret Infeld, Kramer Wahlberg, Jillian Cicero, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 29, 2025
Mechanical Stretch Reduces Fibroblast Activation in Heart Failure with Reduced Ejection FractionDaniel N Silverman, Ahmed A Ismail, Lauren Wakefield, et al.
Journal of the American Heart Association|April 10, 2025
Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast PopulationsRachel M Biggs, Yuhua Zhang, Daniel N Silverman, et al.
Journal of Cardiac Failure|May 21, 2022
Outcomes in Patients With LVADs Undergoing Simultaneous Heart-Kidney TransplantationJessica Atkins, Nicholas R Hess, Sheng Fu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
JAMA Network Open|December 5, 2019
Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT TrialDaniel N Silverman, Timothy B Plante, Margaret Infeld, et al.
JACC. Heart Failure|May 4, 2023
Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection FractionSuzanne V Arnold, Daniel N Silverman, Kensey Gosch, et al.
Current Heart Failure Reports|March 19, 2025
Epicardial Fat in Heart Failure and Preserved Ejection Fraction: Novel Insights and Future PerspectivesJacob Whitman, Elie Kozaily, Erin D Michos, et al.
Heart Rhythm O2|March 4, 2022
Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction: Design and rationale for the <i>my</i>PACE randomized controlled trialMargaret Infeld, Kramer Wahlberg, Jillian Cicero, et al.
Heart Rhythm O2|February 19, 2021
An approach towards individualized lower rate settings for pacemakersMargaret Infeld, Robert Avram, Kramer Wahlberg, et al.
The American Journal of Cardiology|December 15, 2021
Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial)Daniel N Silverman, Jeanne du Fay de Lavallaz, Timothy B Plante, et al.
JAMA Cardiology|February 1, 2023
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical TrialMargaret Infeld, Kramer Wahlberg, Jillian Cicero, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 29, 2025
Mechanical Stretch Reduces Fibroblast Activation in Heart Failure with Reduced Ejection FractionDaniel N Silverman, Ahmed A Ismail, Lauren Wakefield, et al.
Journal of the American Heart Association|April 10, 2025
Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast PopulationsRachel M Biggs, Yuhua Zhang, Daniel N Silverman, et al.
Journal of Cardiac Failure|May 21, 2022
Outcomes in Patients With LVADs Undergoing Simultaneous Heart-Kidney TransplantationJessica Atkins, Nicholas R Hess, Sheng Fu, et al.
Pageof 3